12
Participants
Start Date
December 8, 2017
Primary Completion Date
November 30, 2018
Study Completion Date
November 30, 2018
Antwerp University Hospital, Edegem
Royal Adelaide Hospital, Adelaide
NYU Neurogenetics, New York
Northwell Health, Great Neck
University of Pittsburgh, Pittsburgh
Penn State Hershey Medical Center, Hershey
Duke University Medical Center, Durham
Emory University, Decatur
University of Florida Clinical Research Center, Gainesville
Ohio State University, Columbus
Cincinnati Children's Hospital, Cincinnati
University of Minnesota Medical Center, Minneapolis
University of Kansas Medical Center, Kansas City
The University of Texas Health Science Center San Antonio, San Antonio
University of California, Irvine, Irvine
Oregon Health& Science University, Portland
Baystate Medical Center, Springfield
Hackensack University Medical Center, Hackensack
Jacobs & Levy Genomic Medicine and Research Program, Morristown
Alberta Children's Hospital, Calgary
McMaster University Medical Center, Hamilton
Lead Sponsor
Amicus Therapeutics
INDUSTRY